Effect of ApoE Isoforms on Mitochondria in Alzheimer Disease

Overview

Journal Neurology

Specialty Neurology

Date 2020 May 28

PMID 32457210

Citations 58

Authors

JunXiang Yin

Eric M Reiman

Thomas G Beach

Geidy E Serrano

Marwan N Sabbagh

Megan Nielsen

Richard J Caselli

Jiong Shi

Affiliations

Soon will be listed here.

Abstract

Objective: To test the hypothesis that ApoE isoforms affect mitochondrial structure and function that are related to cognitive impairment in Alzheimer disease (AD), we systematically investigated the effects of ApoE isoforms on mitochondrial biogenesis and dynamics, oxidative stress, synapses, and cognitive performance in AD.

Methods: We obtained postmortem human brain tissues and measured proteins that are responsible for mitochondrial biogenesis (peroxisome proliferator-activated receptor-gamma coactivator-1α [PGC-1α] and sirtuin 3 [SIRT3]), for mitochondrial dynamics (mitofusin 1 [MFN1], mitofusin 2 [MFN2], and dynamin-like protein 1 [DLP1]), for oxidative stress (superoxide dismutase 2 [SOD2] and forkhead-box protein O3a [Foxo3a]), and for synapses (postsynaptic density protein 95 [PSD95] and synapsin1 [Syn1]). A total of 46 cases were enrolled, including ApoE-ɛ4 carriers (n = 21) and noncarriers (n = 25).

Results: Levels of these proteins were compared between ApoE-ɛ4 carriers and noncarriers. ApoE-ɛ4 was associated with impaired mitochondrial structure and function, oxidative stress, and synaptic integrity in the human brain. Correlation analysis revealed that mitochondrial proteins and the synaptic protein were strongly associated with cognitive performance.

Conclusion: ApoE isoforms influence mitochondrial structure and function, which likely leads to alteration in oxidative stress, synapses, and cognitive function. These mitochondria-related proteins may be a harbinger of cognitive decline in ApoE-ɛ4 carriers and provide novel therapeutic targets for prevention and treatment of AD.

Citing Articles

exacerbates glucocorticoid stress hormone-induced tau pathology via mitochondrial dysfunction.

Yu Q, Du F, Goodman J, Waites C bioRxiv. 2025; .

PMID: 39974942 PMC: 11838549. DOI: 10.1101/2025.02.03.636364.

Multi-functional role of apolipoprotein E in neurodegenerative diseases.

Islam S, Noorani A, Sun Y, Michikawa M, Zou K Front Aging Neurosci. 2025; 17:1535280.

PMID: 39944166 PMC: 11813892. DOI: 10.3389/fnagi.2025.1535280.

THRA1/PGC-1α/SIRT3 pathway regulates oxidative stress and is implicated in hypertension of maternal hypothyroid rat offspring.

Guo J, Shi Y, Yu X, Zhao Y, Wei B, Huo M Hypertens Res. 2024; 48(3):1080-1098.

PMID: 39639130 DOI: 10.1038/s41440-024-02023-9.

Dysregulated RBM24 phosphorylation impairs APOE translation underlying psychological stress-induced cardiovascular disease.

Yang H, Sun L, Bai X, Cai B, Tu Z, Fang C Nat Commun. 2024; 15(1):10181.

PMID: 39580475 PMC: 11585567. DOI: 10.1038/s41467-024-54519-0.

Blood-derived mitochondrial DNA copy number is associated with Alzheimer disease, Alzheimer-related biomarkers and serum metabolites.

Tong T, Zhu C, Farrell J, Khurshid Z, Martin E, Pericak-Vance M Alzheimers Res Ther. 2024; 16(1):234.

PMID: 39444005 PMC: 11515778. DOI: 10.1186/s13195-024-01601-w.

References

Burte F, Carelli V, Chinnery P, Yu-Wai-Man P . Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat Rev Neurol. 2014; 11(1):11-24. DOI: 10.1038/nrneurol.2014.228. View

Yin J, Han P, Song M, Nielsen M, Beach T, Serrano G . Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer's Disease. Mol Neurobiol. 2018; 55(11):8592-8601. PMC: 6677544. DOI: 10.1007/s12035-018-0977-0. View

Yin J, Han P, Tang Z, Liu Q, Shi J . Sirtuin 3 mediates neuroprotection of ketones against ischemic stroke. J Cereb Blood Flow Metab. 2015; 35(11):1783-9. PMC: 4635233. DOI: 10.1038/jcbfm.2015.123. View

Coppi E, Lana D, Cherchi F, Fusco I, Buonvicino D, Urru M . Dexpramipexole enhances hippocampal synaptic plasticity and memory in the rat. Neuropharmacology. 2018; 143:306-316. DOI: 10.1016/j.neuropharm.2018.10.003. View

Shoshan-Barmatz V, Nahon-Crystal E, Shteinfer-Kuzmine A, Gupta R . VDAC1, mitochondrial dysfunction, and Alzheimer's disease. Pharmacol Res. 2018; 131:87-101. DOI: 10.1016/j.phrs.2018.03.010. View

Bulstrode H, Nicoll J, Hudson G, Chinnery P, Di Pietro V, Belli A . Mitochondrial DNA and traumatic brain injury. Ann Neurol. 2014; 75(2):186-95. PMC: 4112718. DOI: 10.1002/ana.24116. View

Lee A, Hirabayashi Y, Kwon S, Lewis Jr T, Polleux F . Emerging roles of mitochondria in synaptic transmission and neurodegeneration. Curr Opin Physiol. 2018; 3:82-93. PMC: 6178220. DOI: 10.1016/j.cophys.2018.03.009. View

Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund L . Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004; 256(3):240-6. DOI: 10.1111/j.1365-2796.2004.01380.x. View

McKhann G, Knopman D, Chertkow H, Hyman B, Jack Jr C, Kawas C . The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):263-9. PMC: 3312024. DOI: 10.1016/j.jalz.2011.03.005. View

10.

Sanchis-Gomar F, Garcia-Gimenez J, Gomez-Cabrera M, Pallardo F . Mitochondrial biogenesis in health and disease. Molecular and therapeutic approaches. Curr Pharm Des. 2014; 20(35):5619-33. DOI: 10.2174/1381612820666140306095106. View

11.

Beach T, Adler C, Sue L, Serrano G, Shill H, Walker D . Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology. 2015; 35(4):354-89. PMC: 4593391. DOI: 10.1111/neup.12189. View

12.

Cid-Castro C, Hernandez-Espinosa D, Moran J . ROS as Regulators of Mitochondrial Dynamics in Neurons. Cell Mol Neurobiol. 2018; 38(5):995-1007. PMC: 11481975. DOI: 10.1007/s10571-018-0584-7. View

13.

Cartoni R, Leger B, Hock M, Praz M, Crettenand A, Pich S . Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol. 2005; 567(Pt 1):349-58. PMC: 1474174. DOI: 10.1113/jphysiol.2005.092031. View

14.

Han P, Tang Z, Yin J, Maalouf M, Beach T, Reiman E . Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity. Neurobiol Aging. 2014; 35(9):2064-71. DOI: 10.1016/j.neurobiolaging.2014.03.022. View

15.

Braidy N, Poljak A, Grant R, Jayasena T, Mansour H, Chan-Ling T . Differential expression of sirtuins in the aging rat brain. Front Cell Neurosci. 2015; 9:167. PMC: 4424846. DOI: 10.3389/fncel.2015.00167. View

16.

Lutz M, Milenkovic I, Regelsberger G, Kovacs G . Distinct patterns of sirtuin expression during progression of Alzheimer's disease. Neuromolecular Med. 2014; 16(2):405-14. DOI: 10.1007/s12017-014-8288-8. View

17.

Han P, Liang W, Baxter L, Yin J, Tang Z, Beach T . Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer disease. Neurology. 2014; 82(19):1724-8. PMC: 4032204. DOI: 10.1212/WNL.0000000000000417. View

18.

Dose J, Huebbe P, Nebel A, Rimbach G . APOE genotype and stress response - a mini review. Lipids Health Dis. 2016; 15:121. PMC: 4960866. DOI: 10.1186/s12944-016-0288-2. View

19.

Harmuth T, Prell-Schicker C, Weber J, Gellerich F, Funke C, Driessen S . Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3. Front Mol Neurosci. 2018; 11:368. PMC: 6192284. DOI: 10.3389/fnmol.2018.00368. View

20.

Bobylev I, Joshi A, Barham M, Neiss W, Lehmann H . Depletion of Mitofusin-2 Causes Mitochondrial Damage in Cisplatin-Induced Neuropathy. Mol Neurobiol. 2017; 55(2):1227-1235. DOI: 10.1007/s12035-016-0364-7. View